Orthofix Medical (OFIX) Liabilities and Shareholders Equity (2010 - 2026)

Orthofix Medical has disclosed Liabilities and Shareholders Equity across 17 years of filings, most recently posting $886.6 million for Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 7.71% year-over-year to $886.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 billion (down 1.71% YoY) and the FY2025 annual result came in at $850.6 million, down 4.77% from the prior year.
• Liabilities and Shareholders Equity improved to $886.6 million in Q1 2026, from $850.6 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $925.3 million in Q4 2023 and troughed at $449.7 million in Q3 2022.
• A 5-year average of $780.0 million and a median of $867.9 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity declined 10.14% — and 2023, when it soared 101.76%.
• Tracing OFIX's Liabilities and Shareholders Equity over 5 years: stood at $458.6 million in 2022, then surged by 101.76% to $925.3 million in 2023, then fell by 3.46% to $893.3 million in 2024, then retreated by 4.77% to $850.6 million in 2025, then grew by 4.23% to $886.6 million in 2026.
• Business Quant data shows OFIX's Liabilities and Shareholders Equity at $886.6 million in Q1 2026, $850.6 million in Q4 2025, and $832.6 million in Q3 2025.